(MedPage Today) — Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging.
The medications still amount to around $500 per month for those without…
Source link : https://www.medpagetoday.com/primarycare/obesity/116389
Author :
Publish date : 2025-07-07 17:18:00
Copyright for syndicated content belongs to the linked Source.
